{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:27:33Z","timestamp":1760142453312,"version":"build-2065373602"},"reference-count":97,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.annfar.2010.02.016","type":"journal-article","created":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T13:45:34Z","timestamp":1269956734000},"page":"e37-e46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["M\u00e9dicaments utilis\u00e9s dans la prise en charge de la pr\u00e9\u00e9clampsie. Pharmacologie et risques f\u0153taux"],"prefix":"10.1016","volume":"29","author":[{"given":"R.","family":"Serreau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annfar.2010.02.016_bib1","unstructured":"Mattison DR, Malek A, Cistola C. Physiologic adaptations to pregnancy: Impact on pharmacokinetics. In: Yaffe-Aranda, ed. Pediatric Pharmacology, Therapeutic Principles in Practice (2nd edition). Philadelphia: WB Saunders Company; 1993. p.\u00a081\u201396."},{"key":"10.1016\/j.annfar.2010.02.016_bib2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/clpt.2008.73","article-title":"Changes in enoxaparin kinetics on anti-Xa activity during pregnancy and implications for antithrombotic therapeutic strategy","volume":"84","author":"Lebaudy","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.annfar.2010.02.016_bib3","unstructured":"Kaufmann P, Schellen I. Placental development. In: Polin RA, Fox WW, eds. Fetal and neonatal physiology. Philadelphia: Saunders; 1992. p.\u00a047\u201356."},{"key":"10.1016\/j.annfar.2010.02.016_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2165\/00003088-199528030-00005","article-title":"Placental transfer of drugs administered to the mother","volume":"28","author":"Pacifici","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.annfar.2010.02.016_bib5","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1096\/fj.07-8688com","article-title":"The ABC trans porter BCRP\/ABCG2\u00a0is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction","volume":"21","author":"Evseenko","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.annfar.2010.02.016_bib6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.reprotox.2006.01.007","article-title":"P-glycoprotein in the placenta: expression, localization, regulation and function","volume":"22","author":"Ceckova-Novotna","year":"2006","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.annfar.2010.02.016_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1471-0528.2006.01200.x","article-title":"Nicardipine in pre-eclamptic patients: placental transfer and disposition in breast milk","volume":"114","author":"Bartels","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.annfar.2010.02.016_bib8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00003088-199528050-00001","article-title":"Pharmacological treatment of the fetus: Clinical pharmacokinetic considerations","volume":"28","author":"Ward","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.annfar.2010.02.016_bib9","first-page":"634","article-title":"Clonidine Hydrochloride \u2013 A safe and Effective Antihypertensive Agent in Pregnancy","volume":"66","author":"Phippard","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib10","first-page":"519","article-title":"Clonidine et traitement des urgences hypertensives de la femme enceinte","volume":"82","author":"Wing-Tin","year":"1987","journal-title":"Rev Fran Gynecol Obstet"},{"key":"10.1016\/j.annfar.2010.02.016_bib11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejogrb.2005.09.013","article-title":"Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil","volume":"127","author":"Wacker","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.annfar.2010.02.016_bib12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0002-9378(12)90905-9","article-title":"Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancy-induced hypertension","volume":"168","author":"Montan","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib13","first-page":"871","article-title":"Controlled Trial of Hypotensive Agents Hypertension in Pregnancy","volume":"30","author":"Baker","year":"1968","journal-title":"Br Heart J"},{"key":"10.1016\/j.annfar.2010.02.016_bib14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/bmj.283.6289.471","article-title":"Maternal methyldopa treatment and neonatal blood pressure","volume":"283","author":"Whitelaw","year":"1981","journal-title":"Br Med J"},{"key":"10.1016\/j.annfar.2010.02.016_bib15","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1471-0528.1978.tb15856.x","article-title":"Neonatal head circumference and the treatment of maternal hypertension","volume":"85","author":"Moar","year":"1978","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1471-0528.1980.tb04420.x","article-title":"Hypertension during pregnancy with and without specific treatment; the development of the children at the age of four years","volume":"87","author":"Ounsted","year":"1980","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib17","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1136\/bmj.286.6382.1927","article-title":"Randomized controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy","volume":"286","author":"Fidler","year":"1983","journal-title":"Br J Med"},{"key":"10.1016\/j.annfar.2010.02.016_bib18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0002-9378(95)90123-X","article-title":"Methyldopa hepatotoxicity in pregnancy: A case report","volume":"172","author":"Smith","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib19","first-page":"143","article-title":"Neonatal nasal obstruction associated with methyldopa treatment during pregnancy","volume":"144","author":"Le Gras","year":"1990","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.annfar.2010.02.016_bib20","doi-asserted-by":"crossref","unstructured":"Clivaz Mariotti L, Saudan P, Landau Cahana R, Pech\u00e8re-Bertschi A. Hypertension in pregnancy. Rev Med Suisse 2007;3:2012, 2015\u20136, 2018.","DOI":"10.53738\/REVMED.2007.3.124.2012"},{"key":"10.1016\/j.annfar.2010.02.016_bib21","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/bmj.327.7421.955","article-title":"Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis","volume":"327","author":"Magee","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.annfar.2010.02.016_bib22","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0002-9378(93)90048-N","article-title":"Effects of hydralazine on pregnant rats and their fetuses","volume":"169","author":"Pryde","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jama.1977.03270300068010","article-title":"Hypotensive Sequelae of Diazoxide and Hydralazine Therapy","volume":"237","author":"Henrich","year":"1977","journal-title":"JAMA"},{"key":"10.1016\/j.annfar.2010.02.016_bib24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00007611-198605000-00010","article-title":"Fetal distress after hydralazine therapy for severe pregnancy-induced hypertension","volume":"79","author":"Spinnato","year":"1986","journal-title":"South Med J"},{"key":"10.1016\/j.annfar.2010.02.016_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-2007-999491","article-title":"Severe pre-eclampsia: Is vasodilation therapy with hydralazine dangerous for the preterm fetus?","volume":"7","author":"Derham","year":"1990","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.annfar.2010.02.016_bib26","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1055\/s-2007-999378","article-title":"Should continuous hydralazine infusions be utilized in severe pregnancy-induced hypertension?","volume":"8","author":"Kirshon","year":"1991","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.annfar.2010.02.016_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0028-2243(89)90068-3","article-title":"Lupus-like syndrome in a mother and newborn following administration of hydralazine: A case report","volume":"30","author":"Yemini","year":"1989","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.annfar.2010.02.016_bib28","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1056\/NEJM198011203032112","article-title":"Hydralazine-induced neonatal trombocytopenia","volume":"303","author":"Widerl\u00f6v","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2010.02.016_bib29","first-page":"352","article-title":"Hydralazine-induced hepatitis in pregnancy","volume":"31","author":"Hod","year":"1986","journal-title":"Int J Fertil"},{"key":"10.1016\/j.annfar.2010.02.016_bib30","first-page":"CD001449","article-title":"Drugs for treatment of very high blood pressure during pregnancy","volume":"3","author":"Duley","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.annfar.2010.02.016_bib31","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0002-9378(87)80104-7","article-title":"Nifedipine: Effects on fetal and maternal hemodynamics in pregnant sheep","volume":"157","author":"Harake","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib32","first-page":"21A","article-title":"Some effects of Cordipin\u00ae (nifedipine) administered during pregnancy in the rats","volume":"29","author":"Cabov","year":"1984","journal-title":"Teratology"},{"key":"10.1016\/j.annfar.2010.02.016_bib33","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0002-9378(11)91592-0","article-title":"The effects of nifedipine on pregnancy outcome and morphology of the placenta, uterus, and cervix during late pregnancy in the rat","volume":"167","author":"Vasilenko","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib34","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1203\/00006450-198911000-00016","article-title":"Fetal cardiovascular effects of nifedipine in Rats","volume":"26","author":"Momma","year":"1989","journal-title":"Pediatr Res"},{"key":"10.1016\/j.annfar.2010.02.016_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000292979","article-title":"Effects of nifedipine on normotensive rat placental blood flow, placental weight and fetal weight","volume":"32","author":"Furuhashi","year":"1991","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.annfar.2010.02.016_bib36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0002-9378(11)91624-X","article-title":"Nifedipine for treatment of preterm labor: A historic prospective study","volume":"167","author":"Murray","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib37","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1471-0528.1993.tb15120.x","article-title":"Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33\u00a0weeks","volume":"100","author":"Impey","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0002-9378(89)90226-3","article-title":"Neuromuscular blockage with magnesium sulfate and nifedipine","volume":"161","author":"Snyder","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib39","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0002-9378(88)80072-3","article-title":"Magnesium plus nifedipine: Potentiation of hypotensive effect in pre-eclampsia?","volume":"159","author":"Waisman","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib40","first-page":"908","article-title":"Nicardipine treatment of hypertension during pregnancy","volume":"81","author":"Carbonne","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib41","first-page":"354","article-title":"Nicardipine versus metoprolol in the treatment of hypertension during pregnancy: A randomized comparative trial","volume":"84","author":"Jannet","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib42","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s11906-006-0030-y","article-title":"Pathophysiology and medical management of systemic hypertension in preeclampsia","volume":"8","author":"Frishman","year":"2006","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.annfar.2010.02.016_bib43","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1097\/01.hjh.0000188729.73807.16","article-title":"Intravenous use of the calcium-channel blocker nicardipine as second-line treatment in severe, early-onset pre-eclamptic patients","volume":"23","author":"Hanff","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.annfar.2010.02.016_bib44","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00134-002-1406-3","article-title":"Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol","volume":"28","author":"Elatrous","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.annfar.2010.02.016_bib45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0020-7292(01)00569-0","article-title":"Long-term treatment with nicardipine for severe pre-eclampsia","volume":"76","author":"Seki","year":"2002","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.annfar.2010.02.016_bib46","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.2741\/2279","article-title":"Evidence-based management for preeclampsia","volume":"12","author":"von Dadelszen","year":"2007","journal-title":"Front Biosci"},{"key":"10.1016\/j.annfar.2010.02.016_bib47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejogrb.2006.02.015","article-title":"or the HYLA treatment study. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial","volume":"128","author":"Vigil-De Gracia","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.annfar.2010.02.016_bib48","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jgyn.2007.03.004","article-title":"Pulmonary edema during calcium-channel blockers therapy: role of predisposing or pharmacologic factors?","volume":"36","author":"Akerman","year":"2007","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.annfar.2010.02.016_bib49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1185\/1463009001527697","article-title":"Excretion of nicardipine (Loxen\u00ae) in human milk","volume":"4","author":"Jarreau","year":"2000","journal-title":"Paediatric and Perinatal drug Therapy"},{"key":"10.1016\/j.annfar.2010.02.016_bib50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/00016348209156947","article-title":"Transfer of propranolol and sotalol across the human placenta: Their effect on maternal and fetal plasma renin activity","volume":"61","author":"Erkkola","year":"1982","journal-title":"Acta Obstet Gynaecol Scand"},{"key":"10.1016\/j.annfar.2010.02.016_bib51","first-page":"812","article-title":"Propranolol therapy during pregnancy, labor, and delivery: Evidence for transplacental drug transfer and impaired neonatal drug disposition","volume":"91","author":"Cottril","year":"1977","journal-title":"Pediatrics"},{"key":"10.1016\/j.annfar.2010.02.016_bib52","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/00016348409157127","article-title":"Labetalol for the treatment of hypertension in pregnancy: Pharmacokinetics and effects on the uteroplacental blood flow","volume":"118","author":"Nylund","year":"1984","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.annfar.2010.02.016_bib53","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1471-0528.1986.tb07950.x","article-title":"The effect of maternal labetalol on the newborn infant","volume":"93","author":"MacPherson","year":"1986","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib54","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1471-0528.1989.tb01574.x","article-title":"The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension","volume":"96","author":"Pickles","year":"1989","journal-title":"Br J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib55","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1471-0528.2004.00525.x","article-title":"Developmental toxicity of the angiotensin II type 1\u00a0receptor antagonists during human pregnancy: a report of 10\u00a0cases","volume":"112","author":"Serreau","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.annfar.2010.02.016_bib56","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM198912143212404","article-title":"The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects","volume":"321","author":"Werler","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2010.02.016_bib57","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(76)93025-7","article-title":"Aspirin and congenital malformations","volume":"1","author":"Slone","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.annfar.2010.02.016_bib58","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/(SICI)1096-9926(199606)54:2<84::AID-TERA4>3.0.CO;2-4","article-title":"Maternal Medications and Environmental Exposures as Risk Factors for Gastroschisis","volume":"54","author":"Torfs","year":"1996","journal-title":"Teratology"},{"key":"10.1016\/j.annfar.2010.02.016_bib59","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/(SICI)1096-9926(199710)56:4<241::AID-TERA2>3.0.CO;2-1","article-title":"Prenatal Exposure to Salicylates and Gastroschisis: A Case-Control Study","volume":"56","author":"Martinez-Frias","year":"1997","journal-title":"Teratology"},{"key":"10.1016\/j.annfar.2010.02.016_bib60","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000263620","article-title":"Contribution of demographic and environmental factors to the etiology of gastroschisis: a hypothesis","volume":"6","author":"Drongowski","year":"1991","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.annfar.2010.02.016_bib61","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(73)92934-6","article-title":"Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour","volume":"2","author":"Lewis","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.annfar.2010.02.016_bib62","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0022-3476(78)80453-3","article-title":"Morphologic analysis of the pulmonary vascular bed in infants exposed in utero to prostaglandin synthetase inhibitors","volume":"92","author":"Levin","year":"1978","journal-title":"J Pediatr"},{"key":"10.1016\/j.annfar.2010.02.016_bib63","first-page":"52S","article-title":"Neonatal intracranial hemorrhage and maternal use of aspirin","volume":"58","author":"Rumack","year":"1981","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib64","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0140-6736(94)92452-X","article-title":"Follow-up of children in the Italian Study of Aspirin in Pregnancy","volume":"348","author":"Parazzini","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.annfar.2010.02.016_bib65","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJM198908103210603","article-title":"The use of aspirin to prevent pregnancy-included hypertension and lower the ratio of thromboxane A2\u00a0to prostacyclin in relatively high risk pregnancies","volume":"321","author":"Schiff","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2010.02.016_bib66","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0002-9378(88)80034-6","article-title":"Low-dose aspirin therapy improves fetal weight in umbilical placental insufficiency","volume":"159","author":"Trudinger","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib67","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM198908103210604","article-title":"Effects of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension","volume":"321","author":"Benigni","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2010.02.016_bib68","doi-asserted-by":"crossref","unstructured":"CLASP Collaborative Group. Low-dose aspirin in pregnancy and early chilhood development: follow up of the collaborative low-dose aspirin study in pregnancy. Br J Obstet Gynecol 1995;102:861\u20138.","DOI":"10.1111\/j.1471-0528.1995.tb10872.x"},{"key":"10.1016\/j.annfar.2010.02.016_bib69","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM198210073071502","article-title":"Effects of acetylsalicylic-acid ingestion on maternal and neonatal hemostasis","volume":"307","author":"Gross","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2010.02.016_bib70","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/0002-9378(95)90495-6","article-title":"Low-dose aspirin in nulliparous women: Safety of continuous epidural block and correlation between bleeding time and maternal-neonatal bleeding complications","volume":"172","author":"Sibai","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib71","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0038-1642376","article-title":"Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin\u00ae) in patients with venous thromboembolism and contraindications for coumarin","volume":"71","author":"Monreal","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.02.016_bib72","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2010.02.016_bib73","doi-asserted-by":"crossref","first-page":"524S","DOI":"10.1378\/chest.114.5_Supplement.524S","article-title":"Use of antithrombotic agents during pregnancy","volume":"114","author":"Hirsh","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.annfar.2010.02.016_bib74","first-page":"55","article-title":"Anticoagulant Treatment during Pregnancy: An Update","volume":"24","author":"Dizon-Townson","year":"1998","journal-title":"Thromb Hemostas"},{"key":"10.1016\/j.annfar.2010.02.016_bib75","first-page":"20","article-title":"Traitement anticoagulant de la maladie thromboembolique et grossesse","volume":"280","author":"Samama","year":"1997","journal-title":"La lettre du cardiologue"},{"key":"10.1016\/j.annfar.2010.02.016_bib76","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1055\/s-0038-1661560","article-title":"A low molecular weight heparin alters the fetal coagulation system in the pregnant sheep","volume":"55","author":"Andrew","year":"1986","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.02.016_bib77","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0020-7292(94)90351-4","article-title":"Thromboembolic prophylaxis with low molecular weight heparin during pregnancy","volume":"47","author":"Rasmussen","year":"1994","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.annfar.2010.02.016_bib78","unstructured":"Horellou MH, Conard J, Achkar A, Hadjez JM, Elalamy I, Samama M. Prevention of thrombosis with unfractionated heparin and low molecular weight heparins during 41\u00a0pregnancies in 31\u00a0women. Haemost 1996A;26:071."},{"key":"10.1016\/j.annfar.2010.02.016_bib79","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0029-7844(95)00452-1","article-title":"Low-molecular-weight-heparin during pregnancy and delivery: preliminary experience with 41\u00a0pregnancies","volume":"87","author":"Dulitzki","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib80","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0301-2115(97)00110-3","article-title":"Thrombosis prophylaxis after treatment during pregnancy","volume":"74","author":"Daskalakis","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.annfar.2010.02.016_bib81","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0038-1655903","article-title":"Thromboprophylaxis with low molecular weight heparin (Fragmin\u00ae) in hight risk pregnancies","volume":"77","author":"Hunt","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.02.016_bib82","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0002-9378(97)70403-4","article-title":"Low-molecular-weight heparin for obstetric thromboprophylaxis: Experience of sixty-nine pregnancies in sixty-one women at hight risk","volume":"176","author":"Nelson-Piercy","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib83","first-page":"1","article-title":"Thromboprophylaxis with low molecular mass heparin, Fragmin\u00ae (dalteparin), during pregnancy - a longitudinal safety study","volume":"9","author":"Blomback","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.annfar.2010.02.016_bib84","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0049-3848(99)00110-3","article-title":"Thromboprophylaxis with Low Molecular Weight Heparin (Dalteparin) in Pregnancy","volume":"96","author":"Pettila","year":"1999","journal-title":"Thromb Res"},{"key":"10.1016\/j.annfar.2010.02.016_bib85","first-page":"101","article-title":"Is there a safe anticoagulation protocol for pregnant women with prosthetic valves?","volume":"25","author":"Arnaout","year":"1998","journal-title":"Clin Exp Obst Gyn"},{"key":"10.1016\/j.annfar.2010.02.016_bib86","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0301-2115(98)00083-9","article-title":"Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: A preliminary study","volume":"80","author":"Riyazi","year":"1998","journal-title":"Eur J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib87","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","article-title":"Safety of low-molecular-weight heparin in pregnancy: A systematic review","volume":"81","author":"Sanson","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.annfar.2010.02.016_bib88","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ajog.2007.04.022","article-title":"Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes","volume":"197","author":"Duhl","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib89","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1055\/s-2004-815630","article-title":"Anticoagulation during pregnancy","volume":"29","author":"Pabinger","year":"2003","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.annfar.2010.02.016_bib90","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/GCO.0b013e3282f10e33","article-title":"The use of low-molecular-weight heparins in pregnancy-how safe are they?","volume":"19","author":"Deruelle","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib91","first-page":"822","article-title":"Puerperal hypertension, stroke, and seizures after suppression of lactation with bromocriptine","volume":"66","author":"Katz","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib92","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0002-9378(86)90829-X","article-title":"Acute myocardial infraction in the puerperium in patients receiving bromocriptine","volume":"155","author":"Iffy","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annfar.2010.02.016_bib93","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7326\/0003-4819-118-3-199302010-00008","article-title":"Possible bromocriptine-induced myocardial infraction","volume":"118","author":"Larrazet","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annfar.2010.02.016_bib94","first-page":"99","article-title":"Lethal cardiovascular complications in patients receiving bromocriptine for ablactation","volume":"14","author":"Iffy","year":"1995","journal-title":"Med Law"},{"key":"10.1016\/j.annfar.2010.02.016_bib95","first-page":"309","article-title":"Severe cerebral accidents postpartum in patients taking bromocriptine for milk suppression","volume":"32","author":"Iffy","year":"1996","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.annfar.2010.02.016_bib96","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00045391-199803000-00010","article-title":"Severe cardial dysrhythmia in patients using bromocriptine postpartum","volume":"5","author":"Ifffy","year":"1998","journal-title":"Am J Ther"},{"key":"10.1016\/j.annfar.2010.02.016_bib97","first-page":"448","article-title":"Postpartum myocardial infarction in a patient receiving bromocriptine","volume":"74","author":"Ruch","year":"1989","journal-title":"Obstet Gynecol"}],"container-title":["Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0750765810000687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0750765810000687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:12:05Z","timestamp":1760091125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0750765810000687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":97,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0750765810000687"],"URL":"https:\/\/doi.org\/10.1016\/j.annfar.2010.02.016","relation":{},"ISSN":["0750-7658"],"issn-type":[{"type":"print","value":"0750-7658"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M\u00e9dicaments utilis\u00e9s dans la prise en charge de la pr\u00e9\u00e9clampsie. Pharmacologie et risques f\u0153taux","name":"articletitle","label":"Article Title"},{"value":"Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annfar.2010.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}